Aqr Capital Management LLC Pacira Bio Sciences, Inc. Transaction History

Aqr Capital Management LLC

$75.6 Billion
Q4 2024

A detailed history of Aqr Capital Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Aqr Capital Management LLC holds 288,499 shares of PCRX stock, worth $6.66 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

288,499

Previous 546,208 47.18%

Holding current value

$6.66 Million

Previous $8.23 Million 33.92%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$15.3 - $20.33 $3.94 Million - $5.24 Million	-257,709 Reduced 47.18%	288,499 $5.44 Million
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $5.6 Million - $13.6 Million	478,595 Added 707.84%	546,208 $8.23 Million
Q2 2024 Aug 14, 2024	BUY	$25.5 - $31.51 $150,909 - $186,476	5,918 Added 9.59%	67,613 $1.93 Million
Q1 2024 May 15, 2024	SELL	$27.7 - $35.48 $2.25 Million - $2.88 Million	-81,079 Reduced 56.79%	61,695 $1.8 Million
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $893,642 - $1.16 Million	33,953 Added 31.2%	142,774 $4.82 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $2.09 Million - $2.73 Million	68,061 Added 166.98%	108,821 $3.34 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $47.5 $422,459 - $555,560	11,696 Added 40.24%	40,760 $1.63 Million
Q1 2023 May 15, 2023	BUY	$35.53 - $43.38 $1.03 Million - $1.26 Million	29,064 New	29,064 $1.19 Million
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $465,569 - $550,611	-7,867 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $467,184 - $620,865	-7,877 Reduced 50.03%	7,867 $551,000
Q4 2020 Feb 16, 2021	SELL	$50.47 - $66.26 $150,148 - $197,123	-2,975 Reduced 15.89%	15,744 $942,000
Q3 2020 Nov 16, 2020	SELL	$51.97 - $63.0 $1.62 Million - $1.97 Million	-31,197 Reduced 62.5%	18,719 $1.13 Million
Q2 2020 Aug 17, 2020	SELL	$30.8 - $52.47 $101,486 - $172,888	-3,295 Reduced 6.19%	49,916 $2.62 Million
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $672,654 - $1.2 Million	23,685 Added 80.22%	53,211 $1.78 Million
Q4 2019 Feb 14, 2020	SELL	$36.31 - $46.83 $3.31 Million - $4.27 Million	-91,263 Reduced 75.56%	29,526 $1.34 Million
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $593,810 - $749,173	-16,652 Reduced 12.12%	120,789 $4.6 Million
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $503,605 - $660,594	-13,771 Reduced 9.11%	137,441 $5.98 Million
Q1 2019 May 14, 2019	BUY	$36.47 - $42.17 $2.69 Million - $3.11 Million	73,862 Added 95.49%	151,212 $5.76 Million
Q4 2018 Feb 14, 2019	BUY	$41.31 - $52.16 $2.99 Million - $3.77 Million	72,259 Added 1419.35%	77,350 $3.33 Million
Q3 2018 Nov 15, 2018	SELL	$32.85 - $52.0 $661,697 - $1.05 Million	-20,143 Reduced 79.82%	5,091 $250,000
Q2 2018 Aug 14, 2018	SELL	$27.5 - $39.8 $1.78 Million - $2.57 Million	-64,594 Reduced 71.91%	25,234 $809,000
Q1 2018 May 15, 2018	BUY	$29.98 - $46.35 $2.69 Million - $4.16 Million	89,828 New	89,828 $2.8 Million

Others Institutions Holding PCRX

# of Institutions

260

Shares Held

49.8M

Call Options Held

1.03M

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.06B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Account

Aqr Capital Management LLC Pacira Bio Sciences, Inc. Transaction History